Effects of caffeine on intermittent hypoxia in infants born prematurely: A randomized clinical trial

JAMA Pediatrics

Volumn 168, Issue 3, 2014, Pages 250-257

  Rhein, Lawrence M ^a   Dobson, Nicole R ^b   Darnall, Robert A ^c   Corwin, Michael J ^d,e   Heeren, Tim C ^f   Poets, Christian F ^g   McEntire, Betty L ^h   Hunt, Carl E ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h The American SIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CAFFEINE CITRATE; HEMOGLOBIN;

ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFANT; INTERMITTENT HYPOXIA; MALE; MULTICENTER STUDY; NEWBORN INTENSIVE CARE; OXYGEN SATURATION; PREMATURITY; PRIORITY JOURNAL; PULSE OXIMETER; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; UNITED STATES;

ANOXIA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; OXYGEN; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84896787097     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.4371     Document Type: Article

References (39)

1. Ruehland WR, Rochford PD, O'Donoghue FJ, Pierce RJ, Singh P, Thornton AT. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep. 2009;32(2):150-157.
2. Urlesberger B, Kaspirek A, Pichler G, Müller W. Apnoea of prematurity and changes in cerebral oxygenation and cerebral blood volume. Neuropediatrics. 1999;30(1):29-33.
3. Poets CF. Apnea of prematurity: what can observational studies tell us about pathophysiology? Sleep Med. 2010;11(7):701-707.
4. Mathew OP. Apnea of prematurity: pathogenesis and management strategies. J Perinatol. 2011;31(5):302-310.
5. Nagata N, Saji M, Ito T, Ikeno S, Takahashi H, Terakawa N. Repetitive intermittent hypoxia-ischemia and brain damage in neonatal rats. Brain Dev. 2000;22(5):315-320.
6. Prabhakar NR. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol (1985). 2001;90(5):1986-1994.
7. Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci. 2003;26(1):239-266.
8. Douglas RM, Miyasaka N, Takahashi K, Latuszek-Barrantes A, Haddad GG, Hetherington HP. Chronic intermittent but not constant hypoxia decreases NAA/Cr ratios in neonatal mouse hippocampus and thalamus. Am J Physiol Regul Integr Comp Physiol. 2007;292(3):R1254-R1259.
9. Machaalani R, Waters KA. Postnatal nicotine and/or intermittent hypercapnic hypoxia effects on apoptotic markers in the developing piglet brainstem medulla. Neuroscience. 2006;142(1):107-117.
10. Ratner V, Kishkurno SV, Slinko SK, et al. The contribution of intermittent hypoxemia to late neurological handicap in mice with hyperoxia-induced lung injury. Neonatology. 2007;92(1):50-58.
11. Ratner V, Slinko S, Utkina-Sosunova I, Starkov A, Polin RA, Ten VS. Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia. Neonatology. 2009;95(4):299-305.
12. Di Fiore JM, Bloom JN, Orge F, et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr. 2010;157(1):69-73.
13. Hunt CE, Corwin MJ, Weese-Mayer DE, et al; Collaborative Home Infant Monitoring Evaluation (CHIME) tudy Group. Longitudinal assessment of hemoglobin oxygen saturation in preterm and term infants in the irst six months of life. J Pediatr. 2011;159(3):377-383.
14. Poets CF, Stebbens VA, Alexander JR, Arrowsmith WA, Salfield SA, Southall DP. Arterial oxygen saturation in preterm infants at discharge from the hospital and six weeks later. J Pediatr. 1992;120(3):447-454.
15. Ramanathan R, CorwinMJ, Hunt CE, et al; Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS. JAMA. 2001;285(17):2199-2207.
16. Côté A, Hum C, Brouillette RT, Themens M. Frequency and timing of recurrent events in infants using home cardiorespiratory monitors. J Pediatr. 1998;132(5):783-789.
17. Hunt CE, CorwinMJ, Baird T, et al; Collaborative Home Infant Monitoring Evaluation study group. Cardiorespiratory events detected by home memory monitoring and one-year neurodevelopmental outcome. J Pediatr. 2004;145(4):465-471.
18. Pillekamp F, Hermann C, Keller T, von Gontard A, Kribs A, Roth B. Factors influencing apnea and bradycardia of prematurity: implications for neurodevelopment. Neonatology. 2007;91(3):155-161.
19. Heyman E, Ohlsson A, Heyman Z, Fong K. The effect of aminophylline on the excursions of the diaphragm in preterm neonates: a randomized double-blind controlled study. Acta Paediatr Scand. 1991;80(3):308-315.
20. Bauer J, Maier K, Linderkamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001;107(4):660-663.
21. Bhatt-Mehta V, Schumacher RE. Treatment of apnea of prematurity. Paediatr Drugs. 2003;5(3):195-210.
22. Schmidt B, Roberts RS, Davis P, et al; Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893-1902.
23. Brockmann PE, Poets A, Urschitz MS, Sokollik C, Poets CF. Reference values for pulse oximetry recordings in healthy term neonates during their first 5 days of life. Arch Dis Child Fetal Neonatal Ed. 2011;96(5):F335-F338.
24. Darnall RA, Kattwinkel J, Nattie C, Robinson M. Margin of safety for discharge after apnea in preterm infants. Pediatrics. 1997;100(5):795-801.
25. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997;100(3, pt 1):354-359.
26. Bucher HU, Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? a randomized controlled trial. Eur J Pediatr. 1988;147(3):288-291.
27. Urschitz MS, Guenther A, Eggebrecht E, et al. Snoring, intermittent hypoxia and academic performance in primary school children. Am J Respir Crit Care Med. 2003;168(4):464-468.
28. Bass JL, Corwin M, Gozal D, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics. 2004;114(3):805-816.
29. Ali NJ, Pitson D, Stradling JR. Sleep disordered breathing: effects of adenotonsillectomy on behaviour and psychological functioning. Eur J Pediatr. 1996;155(1):56-62.
30. Kheirandish L, Gozal D, Pequignot JM, Pequignot J, Row BW. Intermittent hypoxia during development induces long-term alterations in spatial working memory, monoamines, and dendritic branching in rat frontal cortex. Pediatr Res. 2005;58(3):594-599.
31. Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB. Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling. Neuroscience. 2003;117(2):417-425.
32. Gray PH, Flenady VJ, Charles BG, Steer PA; Caffeine Collaborative Study Group. Caffeine citrate for very preterm infants: effects on development, temperament and behaviour. J Paediatr Child Health. 2011;47(4):167-172.
33. Schmidt B, Anderson PJ, Doyle LW, et al; Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA. 2012;307(3):275-282.
34. Doyle LW, Cheong J, Hunt RW, et al. Caffeine and brain development in very preterm infants. Ann Neurol. 2010;68(5):734-742.
35. Ahmed SJM, Rich W, Finer NN. The effect of averaging time on oximetry values in the premature infant. Pediatrics. 2010;125(1):e115-e121.
36. Le Guennec JC, Billon B, Paré C. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding. Pediatrics. 1985;76(5):834-840.
37. Carrier O, Pons G, Rey E, et al. Maturation of caffeinemetabolic pathways in infancy. Clin Pharmacol Ther. 1988;44(2):145-151.
38. Thomson AH, Kerr S, Wright S. Population pharmacokinetics of caffeine in neonates and young infants. Ther Drug Monit. 1996;18(3): 245-253.
39. Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit. 2008;30(6):709-716.